[Pharmacologic and clinic pharmacologic study of new ulcer inhibiting drugs (Bispan, Triospan)].
D000818:Animals; D001285:Atropine / Q000627:therapeutic use; D002415:Cats; D002986:Clinical Trials as Topic; D004357:Drug Synergism; D006801:Humans; D051379:Mice; D009132:Muscles / Q000627:therapeutic use*; D010208:Papaverine / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use*; D011804:Quinolines / Q000627:therapeutic use*; D051381:Rats; D013276:Stomach Ulcer / Q000188:drug therapy*
D010879:Piperazines; D000644:Quaternary Ammonium Compounds; D011804:Quinolines; D001285:Atropine; D010208:Papaverine
Pharmakologische und kliniko-pharmakologische Untersuchung neuer ulkushemmender Medikamente (Bispan, Triospan)